Photo of Suman Malempati, M.D.

Suman Malempati M.D.

    • Associate Professor of Pediatrics, Division of Hematology and Oncology School of Medicine

Dr. Malempati's primary research interest is in the evaluation of novel anti-cancer agents for the treatment of pediatric sarcomas through early phase clinical trials. He is director of the Doernbecher Children's Hospital Developmental Therapeutics program and is involved in design and conduct of clinical trials through the Children's Oncology Group. 

Education

  • M.D., University of Washington, St. Louis Missouri 1996
  • B.A., Duke University 1990
  • Residency:

    • Pediatrics, University of New Mexico, 1999
  • Fellowship:

    • Fellowship in pediatric hematology/oncology, Oregon Health & Science University, 2005
  • Certifications:

    • American Board of Pediatrics (general pediatrics), 2000

Memberships and associations

  • Fellow, American Academy of Pediatrics

Publications

  • "Navigating your career path in pediatric hematology/oncology : On and off the beaten track." Pediatric Blood and Cancer In: , Vol. 63, No. 10, 01.10.2016, p. 1723-1730.
  • "Preventive antibiotics in pediatric patients with acute myeloid leukemia (AML)." Pediatric Blood and Cancer  In: , Vol. 62, No. 7, 01.07.2015, p. 1149-1154.
  • "A patient-derived xenograft model of parameningeal embryonal rhabdomyosarcoma for preclinical studies." Sarcoma  In: , Vol. 2015, 826124, 2015.
  • "Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors : A report from the Children's Oncology Group." Pediatric Blood and Cancer In: , Vol. 61, No. 3, 03.2014, p. 452-456.
  • "Langerhans cell histiocytosis."   Wintrobe's Clinical Hematology: Thirteenth Edition. Wolters Kluwer Health Adis (ESP), 2013. p. 1307-1316.
  • "Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors : A Children's Oncology Group study." Pediatric Blood and Cancer In: , Vol. 60, No. 2, 02.2013, p. 237-241.
  • "Overcoming autopsy barriers in pediatric cancer research." Pediatric Blood and Cancer  In: , Vol. 60, No. 2, 02.2013, p. 204-209.
  • " 18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models." Pediatric Blood and Cancer  In: , Vol. 59, No. 3, 09.2012, p. 485-492.
  • "Rhabdomyosarcoma : Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies." Pediatric Blood and Cancer In: , Vol. 59, No. 1, 15.07.2012, p. 5-10.
  • "Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma : A report from the Children's Oncology Group." Journal of Clinical Oncology In: , Vol. 30, No. 3, 20.01.2012, p. 256-262.
  • "Rhabdomyosarcoma in infants younger than 1 year : A report from the children's oncology group." Cancer  In: , Vol. 117, No. 15, 01.08.2011, p. 3493-3501.
  • "Evasion mechanisms to Igf1r inhibition in rhabdomyosarcoma." Molecular Cancer Therapeutics  In: , Vol. 10, No. 4, 04.2011, p. 697-707.
  • "The authors reply." New England Journal of Medicine  In: , Vol. 362, No. 2, 14.01.2010, p. 183.
  • "Videos in clinical medicine. Bone marrow aspiration and biopsy." The New England journal of medicine  In: , Vol. 361, No. 15, 08.10.2009.
  • "Bone marrow aspiration and biopsy." New England Journal of Medicine  In: , Vol. 361, No. 15, 08.10.2009.
  • "Body mass index predicts insulin resistance in survivors of pediatric acute lymphoblastic leukemia." Pediatric Blood and Cancer  In: , Vol. 53, No. 1, 15.07.2009, p. 58-63.
  • "Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia." Pediatric Blood and Cancer  In: , Vol. 52, No. 7, 01.07.2009, p. 814-818.
  • "Emergency Department Presentation of Childhood Cancer." Emergency Medicine Clinics of North America  In: , Vol. 27, No. 3, 2009, p. 477-495.
  • "Outcome after relapse among children with standard-risk acute lymphoblastic leukemia : Children's Oncology Group Study CCG-1952." Journal of Clinical Oncology In: , Vol. 25, No. 36, 20.12.2007, p. 5800-5807.
  • "Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors : The Children's Oncology Group." Journal of Clinical Oncology In: , Vol. 25, No. 12, 20.04.2007, p. 1505-1511.
  • "Neuroblastoma Found in a 4-Year-Old After Rituximab Therapy for Opsoclonus-Myoclonus." Pediatric Neurology  In: , Vol. 35, No. 3, 09.2006, p. 213-215.
  • "Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias." Leukemia In: , Vol. 20, No. 9, 09.2006, p. 1572-1581.
  • "Spontaneous regression of aleukemia congenital leukemia cutis." Pediatric Dermatology In: , Vol. 22, No. 1, 01.2005, p. 26-30.

Additional information

Edit profile